The US Department of Veterans Affairs (VA) has exclusively selected Organon's Hadlima in replacement of Humira (adalimumab) for the VA National Formulary. 21 February 2024
Reform of the procurement policies applied to generic medicines is needed to ensure greater security of supply for patients and health systems, according to Med 19 February 2024
The National Institute for Health and Care Excellence (NICE) has issued a Final Draft Guidance (FDG) recommending GSK’s Omjjara (momelotinib) for myelofibrosis- 15 February 2024
US trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has made clear its opposition to the drug price-setting provisions in the Biden 14 February 2024
Non-governmental organization Médecins Sans Frontières (MSF) has issued a warning about the details of a trade deal that is about to be agreed by India and the 14 February 2024
An Expert View from Ross Maclean, Precision Health Economics, Outcomes Research and Head of Medical Affairs,Precision Value and Health, and the same company's J 5 February 2024
A new cell and gene therapy initiative from the White House will launch with an initial focus on treatments for sickle cell disease (SCD). 1 February 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.